Edward Nardell, MD
About Edward Nardell, MD
Pulmonologist with a special interest in tuberculosis; trained in pulmonary medicine at Massachusetts General Hospital with additional research training at Boston University School of Medicine. While at Boston City Hospital, Dr. Nardell became director of tuberculosis control for the City of Boston. In 1981 he became chief of pulmonary medicine and director of tuberculosis control for the city of Cambridge, positions he held until 2005. His principal academic appointment is as associate professor of medicine, Harvard Medical School, with secondary parallel appointments in the Department of Global Health and Social Medicine and Harvard School of Public Health. In the early 1980's, Dr Nardell was also appointed medical director of tuberculosis control for the Massachusetts Department of Public Health, a position he held for 18 years. In 2002 he joined Partners In Health as Director of Tuberculosis Research. In 2005 he left Cambridge Hospital to assume a full-time research position in the Division of Global Health Equity, Brigham & Women's Hospital. His research interests include the control of multidrug resistant tuberculosis (MDR-TB) in Peru, Russia, and other high-burden countries, with a special research interest in airborne TB transmission and control. Dr. Nardell is currently conducting a research project in South Africa studying the transmission of MDR-TB using large numbers of guinea pigs to quantify the infectiousness of MDR-TB patients and the effectiveness of various control interventions, including ultraviolet germicidal irradiation. [Edward Nardell] With funding from WHO, NIH, USAID, and the Gates Foundation, Dr. Nardell organized and co-chaired the first two-week post-graduate course of its kind designed to build technical capacity for implm in high-burden countries, “Engineering Methods to Control Airborne Infections – an International Perspective,”. He is past-president of the Massachusetts Thoracic Society and the North American Region, International Union Against Tuberculosis and Lung Disease. (Source: http://www.brighamandwomens.org/socialmedicine/Nardellbio.aspx)
PubMed Articles: http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=search&term=Nardell+E+...
Role(s) / Profession(s)
- Academic
- Physician
Organization
- Brigham and Women's Hospital, Division of Global Health Equity
- Harvard Medical School
- Harvard School of Public Health
- Partners In Health - PIH
Work Location(s)
- United States
Language(s)
- English
Edward's Communities
Recent Contributions
-
Edward Nardell, MD replied to "Advice on TB/Respiratory infection control in low resource outpatient settings" in the TB Infection Control community.
Thomas, your suggestions are in keeping with current WHO guidelines. Other things that can be done, in theory, are to decompress crowding by more even use of clinic time and space. It is usual for clinics to be overflowing in the mornings and totally empty in the afternoons as doctors ...
-
Edward Nardell, MD replied to "Curtains in patient rooms with TB" in the TB Infection Control community.
Correction: "Mtb not likely to SURVIVE long"
-
Edward Nardell, MD replied to "Curtains in patient rooms with TB" in the TB Infection Control community.
Curtains, because they are fabric, are easily contaminated by hands and droplets and become fomites for contact spread infection. Not only would Mtb not likely survice long on them, but more importantly, once on a surface, organisms are extremely difficult to re-suspend as airborne particles and that is essentially the ...
-
Edward Nardell, MD replied to "Oxygen tubing being reused- any way to make this safer?" in the TB Infection Control community.
Shaheen, Can an intubated patient get aerosol into the room with a closed system even if they cough? The balloon should prevent anything from exiting at the mouth (of course no seal is 100%) and the sleeve keeps anything exiting at the port. What am I missing?
-
Edward Nardell, MD replied to "UVGI Units, Installation and Maintenance - Training" in the TB Infection Control community.
Mr. Spiteri's response contains many misleading issues that require a moderator's response. 1. The statement that UV in ducts can be effective in controlling airborne pathogens. I would ask WHERE IS THE DATA? More specifically, where is the data for TB? It is easy to show that UV will kill ...
Recent Recommendations
- None at this time.